Literature DB >> 10849365

Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.

M D Christensen1, C Geisler.   

Abstract

Receptors expressing the immunoreceptor tyrosine-based inhibitory motif (ITIM) in their cytoplasmic tail play an important role in the negative regulation of natural killer and B-cell activation. A subpopulation of T cells expresses the ITIM containing killer cell inhibitory receptor (KIR), which recognize MHC class I molecules. Following coligation of KIR with an activating receptor, the tyrosine in the ITIM is phosphorylated and the cytoplasmic protein tyrosine phosphatase SHP-1 is recruited to the ITIM via its SH2 domains. It is still not clear how SHP-1 affects T-cell receptor (TCR) signalling. In this study, we constructed a chimeric TCR-KIR receptor. We demonstrated that SHP-1 is recruited to the chimeric TCR-KIR receptor following T-cell stimulation with either anti-TCR monoclonal antibody (MoAb) or superantigen. However, in spite of this we could not detect any effect of SHP-1 on TCR signalling regarding total protein tyrosine phosphorylation, TCR down-regulation, mobilization of intracellular free calcium, or induction of the activation markers CD69 and CD25.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849365     DOI: 10.1046/j.1365-3083.2000.00727.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.

Authors:  Aimee Merino; Rakhi Malhotra; Matt Morton; Joseph Mulenga; Susan Allen; Eric Hunter; Jianming Tang; Richard A Kaslow
Journal:  J Infect Dis       Date:  2011-01-07       Impact factor: 5.226

2.  KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function.

Authors:  Aimee M Merino; Anne-Sophie Dugast; Craig M Wilson; Paul A Goepfert; Galit Alter; Richard A Kaslow; Jianming Tang
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.